Recent studies show that FDA-approved antiretroviral FTC/TAF may slow aging by reducing retrotransposon activity, highlighting a promising gerotherapeutic approach with broad accessibility. Groundbrea...
Recent studies show aging clocks integrating clinical and microbiome data can predict biological age, enabling personalized anti-aging interventions through tailored diets and therapies. Advancements ...
Senolytic and senomorphic therapies, including Rubedo’s RLS-1496 in Phase 1 trials, target senescent cells to treat aging diseases, boosted by AI-driven discovery and rising investment. New seno...
A new blood test based on p-tau217 biomarker can predict Alzheimer’s symptom onset in 3-4 years with high accuracy, offering early intervention opportunities. Recent studies validate a p-tau217 ...
A new AI system, DeepRare, demonstrates superior accuracy in diagnosing rare diseases using real-time data and self-reflective reasoning, as detailed in a 2026 Nature study, with potential to reduce d...
A Nature Aging study shows mitochondrial stress enhances senolytic drugs like navitoclax, improving senescent cell removal by 40% with metabolic interventions. New research reveals mitochondrial stres...
Personalized nutrition leverages AI and genomic data to create tailored diets, improving metabolic health and reducing chronic diseases, as shown in recent studies and FDA approvals. AI-driven persona...
AI-driven mindfulness tools are personalizing mental health care, reducing anxiety by up to 30% based on recent studies, and improving access for underserved populations globally. AI-enhanced mindfuln...
Analysis of ChatGPT and Gemini’s dietary advice for IBS patients shows mixed accuracy, with trends highlighting AI’s role and the need for professional oversight. Recent studies assess AI ...
This article analyzes the critical role of AI product owners in healthcare, focusing on FDA regulations, real-world case studies, and the balance between innovation and patient safety for improved out...
